Development of a new biomarker for the detection of colorectal cancer using plasma concentrations of amino acids and metabolites
Not Applicable
- Conditions
- Colorectal Cancer
- Registration Number
- JPRN-UMIN000029920
- Lead Sponsor
- Kyorin University School of Medicine The Third Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
A) Subjects who have taken any amino acid-formulations, supplements, and beverage within 8 hours before the blood collection. B) Subjects who have taken meals and beverage other than water within 8 hours before the blood collection. C) Subjects who are under medical treatment for any cancer including colorectal cancer (surgery, drug treatment, chemotherapy, radiation therapy) or who underwent surgery to remove cancer within 1 year. D) Subjects who have double cancer. E) Subjects who are pregnant or breast-feeding. F) Patients of inborn error of metabolism. G) Dialysis patients H) Subjects who are judged as ineligible by the medical doctors who are responsible for this trial as investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma concentrations of metabolites that have amino moieties and other metabolites
- Secondary Outcome Measures
Name Time Method Fasting blood glucose, HbA1c Tumor markers (CEA, CA19-9 etc.) Stage of cancer Site of cancer Result of pathological examination Tissue type of cancer Tumor size Clinical parameters obtained in health chek-up